| Mrs Brenda De La Cruz Goldman, OTR/L | |
|
3327 Nw 50th St, Oklahoma City, OK 73112-5627 | |
| (405) 946-7300 | |
| Not Available |
| Full Name | Mrs Brenda De La Cruz Goldman |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 3327 Nw 50th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841476058 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 1083 (Oklahoma) | Primary |
| Provider Name | Community Hospital Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275593337 PECOS PAC ID: 2466494646 Enrollment ID: O20050527000098 |
News Archive
For the past 100 years, Graham Hospital in east central Illinois has provided the city of Canton and its surrounding communities with outstanding healthcare. Today, Graham Hospital provides a full range of inpatient, outpatient, home care and long-term care services. Not unlike many communities across the country, the area Graham Hospital serves has been faced with economic challenges. Despite those challenges, the emergency department (ED) at Graham has actually seen an increase in revenue, even with a slight drop in patients, due to their relationship with T-System, the nation's leading provider of clinical documentation solutions for emergency departments.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has confirmed that its Peripheral and Central Nervous System Drugs Advisory Committee will review the Company's New Drug Application (NDA) for Fampridine-SR on October 14, 2009.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).
Across the U.S., the relaxation of statewide physical distancing measures that are designed to control the COVID-19 pandemic frequently resulted in an immediate reversal of public health gains against SARS-CoV-2, the virus that causes the disease, researchers from Massachusetts General Hospital (MGH) and colleagues reported.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Brenda De La Cruz Goldman, OTR/L 820 Nw 142nd St, Edmond, OK 73013-1961 Ph: (405) 412-6697 | Mrs Brenda De La Cruz Goldman, OTR/L 3327 Nw 50th St, Oklahoma City, OK 73112-5627 Ph: (405) 946-7300 |
News Archive
For the past 100 years, Graham Hospital in east central Illinois has provided the city of Canton and its surrounding communities with outstanding healthcare. Today, Graham Hospital provides a full range of inpatient, outpatient, home care and long-term care services. Not unlike many communities across the country, the area Graham Hospital serves has been faced with economic challenges. Despite those challenges, the emergency department (ED) at Graham has actually seen an increase in revenue, even with a slight drop in patients, due to their relationship with T-System, the nation's leading provider of clinical documentation solutions for emergency departments.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has confirmed that its Peripheral and Central Nervous System Drugs Advisory Committee will review the Company's New Drug Application (NDA) for Fampridine-SR on October 14, 2009.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).
Across the U.S., the relaxation of statewide physical distancing measures that are designed to control the COVID-19 pandemic frequently resulted in an immediate reversal of public health gains against SARS-CoV-2, the virus that causes the disease, researchers from Massachusetts General Hospital (MGH) and colleagues reported.
› Verified 6 days ago
Jovan Pride, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5701 Se 74th St Ste G, Oklahoma City, OK 73135 Phone: 405-610-1909 Fax: 405-610-1910 | |
Tung Le, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3327 Nw 50th St, Oklahoma City, OK 73112 Phone: 405-946-7300 | |
Dr. Rachele Quinones, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6525 N Meridian Ave, Ste, Oklahoma City, OK 73116 Phone: 405-721-1115 | |
Keli A Boone, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1404 Nw 122nd St, Oklahoma City, OK 73114 Phone: 405-749-8131 | |
Caroline Jean Grubbs, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6400 N Santa Fe Ave, Suite B, Oklahoma City, OK 73116 Phone: 405-840-2903 Fax: 405-840-3256 | |
Ms. Denise Lashaun Shaw, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2828 Nw 57th St Ste 302, Oklahoma City, OK 73112 Phone: 405-840-1253 | |
Kallie Kim, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4220 Se 34th St, Oklahoma City, OK 73165 Phone: 785-213-1894 |